S. 1373 · 118th Congress
Naloxone Affordability Act of 2023
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 118th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
3 cosponsors · 1 D, 2 R
3 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill requires the Government Accountability Office to study health insurance coverage and out-of-pocket costs for naloxone as an over-the-counter medication.
What it does: CRS summary · Introduced in Senate · Apr 27, 2023
Naloxone Affordability Act of 2023
This bill requires the Government Accountability Office to study health insurance coverage and out-of-pocket costs for naloxone as an over-the-counter medication.
Naloxone is a medication that temporarily reverses opioid overdoses. Historically, naloxone required a prescription and so was typically covered by health insurance. However, the Food and Drug Administration approved a naloxone nasal spray (sold under the brand name Narcan) for use without a prescription on March 29, 2023, and health insurance does not generally cover over-the-counter medications.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Naloxone Affordability Act of 2023
Latest action (Apr 27, 2023): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Policy area: Health · Origin: Senate · Introduced: Apr 27, 2023
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.